Skip to content
2000
Volume 5, Issue 1
  • ISSN: 0250-6882
  • E-ISSN: 0250-6882

Abstract

Objective

Assessment of thyroid dysfunction among relatives of patients diagnosed with Hashimoto’s thyroiditis is controversial due to the lack of evidence.

Screening and prediction of thyroid dysfunction among first- and second-degree relatives (FDRs and SDRs) of patients who were previously diagnosed with Hashimoto’s thyroiditis.

Materials and Methods

Three hundred and forty-six asymptomatic relatives of 97 patients diagnosed with Hashimoto’s thyroiditis were enrolled in mixed cross-sectional and prospective assessments for thyroid dysfunction over more than two years (September 2018-December 2020).

Both FDR and SDR were evaluated by thyrotropin (TSH) and thyroid ultrasound at enrollment. Individuals with abnormal TSH were thoroughly evaluated biochemically and were subsequently classified as euthyroid, subclinical, and overt thyroid dysfunction. The future reversion of enrolled individuals with normal and subclinical thyroid function to overt dysfunction was predicted by using the Thyroid Event Amsterdam (THEA) score.

Results

Three-quarters of the participants were non-smoking married women. Thyroid dysfunction was diagnosed among 43% of the participants (n=150), of whom two-thirds (74%) were having overt dysfunction (n=111). Neither the demographic elements nor the initial thyroid function could predict the future thyroid function among those participants. Two out of ten (16%) were having autoimmune thyroid disease (AITD) as part of familial clustering (n=56). Four participants with subclinical hypothyroidism were treated accordingly due to their high THEA score despite the global lower THEA score (5.00±0.44).

Conclusion

Screening of asymptomatic relatives of patients diagnosed with Hashimoto's thyroiditis could help identify the familial background of thyroid diseases in 43% of FDRs and SDRs. One-third may have an underlying autoimmune basis.

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/nemj/10.2174/0102506882249988231205102133
2024-01-01
2025-04-24
The full text of this item is not currently available.

References

  1. GarberJ.R. CobinR.H. GharibH. HennesseyJ.V. KleinI. MechanickJ.I. Pessah-PollackR. SingerP.A. WoeberK.A. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association.Endocr. Pract.2012186988102810.4158/EP12280.GL23246686
    [Google Scholar]
  2. LeFevreM.L. Screening for thyroid dysfunction: U.S. Screening for thyroid dysfunction: U.S. Preventative Services Task Force Recommendation Statement.Ann. Intern. Med.2015162564165110.7326/M15‑048325798805
    [Google Scholar]
  3. AACE2021-A-1018: Thyroid Function Screening in First and Second-Degree Healthy Asymptomatic Relatives of Hashimoto’s Thyroiditis Patients.Available from: https://www.endocrinepractice.org/article/S1530-891X(21)01344-6/fulltext
  4. Kumorowicz-CzochM. Tylek-LemanskaD. WyrobekL. GrodzickaT. StarzykJ. Thyroid developmental anomalies among first-degree relatives of children with thyroid dysgenesis and congenital hypothyroidism.J. Pediatr. Endocrinol. Metab.2012255-641341810.1515/jpem‑2011‑048922876532
    [Google Scholar]
  5. KarakocE. TuranS. AkpinarI. IsguvenP. AdalE. HaklarG. DedeF. BereketA. Screening of parents and siblings of patients with thyroid dysgenesis by thyroid function tests and ultrasound.Horm. Res. Paediatr.200870632933910.1159/00016186318953170
    [Google Scholar]
  6. VillanuevaR. GreenbergD.A. DaviesT.F. TomerY. Sibling recurrence risk in autoimmune thyroid disease.Thyroid200313876176410.1089/10507250376849965314558919
    [Google Scholar]
  7. StriederT.G.A. PrummelM.F. TijssenJ.G.P. EndertE. WiersingaW.M. Risk factors for and prevalence of thyroid disorders in a cross‐sectional study among healthy female relatives of patients with autoimmune thyroid disease.Clin. Endocrinol.200359339640110.1046/j.1365‑2265.2003.01862.x12919165
    [Google Scholar]
  8. Cárdenas-RoldánJ. Rojas-VillarragaA. AnayaJ.M. How do autoimmune diseases cluster in families? A systematic review and meta-analysis.BMC Med.20131117310.1186/1741‑7015‑11‑7323497011
    [Google Scholar]
  9. BothraN. ShahN. GoroshiM. JadhavS. PadalkarS. ThakkarH. TotejaG.S. ShivaneV. LilaA. BandgarT. Hashimoto’s thyroiditis: Relative recurrence risk ratio and implications for screening of first‐degree relatives.Clin. Endocrinol.201787220120610.1111/cen.1332328273382
    [Google Scholar]
  10. ReissD. Family’s construction of reality.Cambridge, Mass.Harvard University Press1981276
    [Google Scholar]
  11. RuggeB. BalshemH. SehgalR. RelevoR. GormanP. HelfandM. Screening and Treatment of Subclinical Hypothyroidism or Hyperthyroidism. Comparative Effectiveness Reviews, No. 24Rockville (MD)Agency for Healthcare Research and Quality (US)201111(12)-EHC033-EF
    [Google Scholar]
  12. StriederT.G.A. TijssenJ.G. WenzelB.E. EndertE. WiersingaW.M. Prediction of progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score.Arch. Intern. Med.2008168151657166310.1001/archinte.168.15.165718695079
    [Google Scholar]
  13. WilsonJ.M.G. JungnerG. World Health OrganizationPrinciples and practice of screening for disease.1968
    [Google Scholar]
  14. GharibH. TuttleR.M. BaskinH.J. FishL.H. SingerP.A. McDermottM.T. Subclinical thyroid dysfunction: A joint statement on management from the American Association of clinical endocrinologists, the American thyroid association, and the endocrine society.Thyroid20051512428, 32-3310.1089/thy.2005.15.2415687817
    [Google Scholar]
  15. GusseklooJ. van ExelE. de CraenA.J. MeindersA.E. FrölichM. WestendorpR.G. Thyroid status, disability and cognitive function, and survival in old age.JAMA2004292212591259910.1001/jama.292.21.259115572717
    [Google Scholar]
  16. SurksM.I. OrtizE. DanielsG.H. SawinC.T. ColN.F. CobinR.H. FranklynJ.A. HershmanJ.M. BurmanK.D. DenkeM.A. GormanC. CooperR.S. WeissmanN.J. Subclinical thyroid disease: Scientific review and guidelines for diagnosis and management.JAMA2004291222823810.1001/jama.291.2.22814722150
    [Google Scholar]
  17. WieboltJ. AchterberghR. den BoerA. van der LeijS. MarschE. SuelmannB. de VriesR. van HaeftenT.W. Clustering of additional autoimmunity behaves differently in Hashimoto’s patients compared with Graves’ patients.Eur. J. Endocrinol.2011164578979410.1530/EJE‑10‑117221378091
    [Google Scholar]
  18. Szyper-KravitzM. MaraiI. ShoenfeldY. Coexistence of thyroid autoimmunity with other autoimmune diseases: Friend or foe? Additional aspects on the mosaic of autoimmunity.Autoimmunity200538324725510.1080/0891693050005019416126513
    [Google Scholar]
  19. BoelaertK. NewbyP.R. SimmondsM.J. HolderR.L. Carr-SmithJ.D. HewardJ.M. ManjiN. AllahabadiaA. ArmitageM. ChatterjeeK.V. LazarusJ.H. PearceS.H. VaidyaB. GoughS.C. FranklynJ.A. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease.Am. J. Med.20101232183.e1183.e910.1016/j.amjmed.2009.06.03020103030
    [Google Scholar]
  20. SurksM.I. GoswamiG. DanielsG.H. The thyrotropin reference range should remain unchanged.J. Clin. Endocrinol. Metab.20059095489549610.1210/jc.2005‑017016148346
    [Google Scholar]
/content/journals/nemj/10.2174/0102506882249988231205102133
Loading
/content/journals/nemj/10.2174/0102506882249988231205102133
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test